Consider participating in a clinical study
Alzheimer’s disease (AD) is frustrating. Sudden outbursts of anger, aggression or agitation can be part of the Alzheimer’s disease progression. Managing these symptoms can be difficult. But, you’re not alone! Doctors are working daily to find treatments.
The HarmonyAD clinical research study is being conducted to determine if an investigational drug given as a pill can safely and effectively reduce the symptoms of agitation and aggression in people with Alzheimer’s disease.
- Be at least 50 years old
- Have a diagnosis of Alzheimer’s disease
- Experience at least moderate agitation and/or aggression
- Exhibit agitation and/or aggression at least once a week
- Have a study partner, informant or caregiver who is willing to support and be involved in the AD patient’s participation in the study
The study will last approximately 3 months, and will include 7 clinic study visits and 4 telephone contact visits.
All participants will be monitored throughout the study, and a team will be on hand to answer all questions related to the study. The investigational drug and study-related procedures will be provided at no cost. Cost of travel and meals related to study visits may be reimbursed.
This clinical research study is for individuals with Alzheimer’s disease.
For More Information
To see if you or your loved one may qualify for study participation:
pre-qualification questions online
questions by telephone